Clinical Trial Update: Dapsone for Acute Ischemia Stroke Study [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that dapsone is being studied for acute ischemic stroke in Phase 2 and Phase 3, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DAPSONE (dapsone)

Snippet

Sponsor: Cidat, S.A. de C.V. | Conditions: Cerebral Stroke, Cerebrovascular Accident, Acute | Phase 2, Phase 3 | Status: UNKNOWN